301096 百誠醫藥
按盤價 
50.200 -2.750 (-5.194%)
50.200 -2.750 (-5.194%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.064 | -3.567 | -2.004 | 10.528 | 8.089 |
| 總資產報酬率 ROA (%) | 0.043 | -2.441 | -1.427 | 8.243 | 6.633 |
| 投入資產回報率 ROIC (%) | 0.045 | -2.575 | -1.542 | 8.966 | 7.062 | 邊際利潤分析 |
| 銷售毛利率 (%) | 47.130 | 39.503 | 51.982 | 65.528 | 67.373 |
| 營業利潤率 (%) | 0.247 | -13.132 | -4.289 | 29.193 | 31.057 |
| 息稅前利潤/營業總收入 (%) | 3.336 | -10.783 | -3.972 | 26.977 | 24.546 |
| 淨利潤/營業總收入 (%) | 0.523 | -13.333 | -6.600 | 26.735 | 31.946 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -1,609.723 | 77.193 | 22.084 | 102.449 | 90.733 |
| 價值變動淨收益/利潤總額(%) | 670.553 | 12.944 | 15.506 | -0.036 | -2.081 |
| 營業外收支淨額/利潤總額(%) | -3.844 | 2.309 | 4.624 | -0.454 | 1.185 | 償債能力分析 |
| 流動比率 (X) | 1.845 | 1.687 | 2.009 | 1.900 | 5.538 |
| 速動比率 (X) | 1.628 | 1.495 | 1.778 | 1.790 | 5.311 |
| 資產負債率 (%) | 33.509 | 32.480 | 30.684 | 26.845 | 15.273 |
| 帶息債務/全部投入資本 (%) | 28.948 | 26.613 | 22.861 | 15.212 | 3.570 |
| 股東權益/帶息債務 (%) | 238.713 | 266.351 | 321.431 | 529.979 | 2,540.417 |
| 股東權益/負債合計 (%) | 198.315 | 207.878 | 225.906 | 272.510 | 554.820 |
| 利息保障倍數 (X) | 1.077 | -4.054 | -7.575 | -12.943 | -3.566 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 293.397 | 220.014 | 126.015 | 61.820 | 67.053 |
| 存貨周轉天數 (天) | 207.822 | 155.259 | 126.454 | 81.715 | 80.748 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 22/09/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
